203 related articles for article (PubMed ID: 29289701)
1. Dopamine transporter knockdown mice in the behavioral pattern monitor: A robust, reproducible model for mania-relevant behaviors.
Kwiatkowski MA; Hellemann G; Sugar CA; Cope ZA; Minassian A; Perry W; Geyer MA; Young JW
Pharmacol Biochem Behav; 2019 Mar; 178():42-50. PubMed ID: 29289701
[TBL] [Abstract][Full Text] [Related]
2. Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania.
Milienne-Petiot M; Geyer MA; Arnt J; Young JW
Psychopharmacology (Berl); 2017 Mar; 234(6):1017-1028. PubMed ID: 28160035
[TBL] [Abstract][Full Text] [Related]
3. Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder.
van Enkhuizen J; Geyer MA; Halberstadt AL; Zhuang X; Young JW
J Affect Disord; 2014 Feb; 155():247-54. PubMed ID: 24287168
[TBL] [Abstract][Full Text] [Related]
4. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration.
Young JW; Goey AK; Minassian A; Perry W; Paulus MP; Geyer MA
Pharmacol Biochem Behav; 2010 Jul; 96(1):7-15. PubMed ID: 20363246
[TBL] [Abstract][Full Text] [Related]
5. Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice.
van Enkhuizen J; Geyer MA; Kooistra K; Young JW
Int J Neuropsychopharmacol; 2013 Jun; 16(5):1021-31. PubMed ID: 23164454
[TBL] [Abstract][Full Text] [Related]
6. Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania.
Young JW; van Enkhuizen J; Winstanley CA; Geyer MA
J Psychopharmacol; 2011 Jul; 25(7):934-43. PubMed ID: 21421642
[TBL] [Abstract][Full Text] [Related]
7. Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice.
Kwiatkowski MA; Roberts BZ; van Enkhuizen J; Ji B; Zhou X; Young JW
Eur Neuropsychopharmacol; 2021 Jan; 42():75-86. PubMed ID: 33191077
[TBL] [Abstract][Full Text] [Related]
8. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior.
Young JW; Goey AK; Minassian A; Perry W; Paulus MP; Geyer MA
Psychopharmacology (Berl); 2010 Feb; 208(3):443-54. PubMed ID: 20020109
[TBL] [Abstract][Full Text] [Related]
9. Blockade of dopamine D
Milienne-Petiot M; Groenink L; Minassian A; Young JW
J Psychopharmacol; 2017 Oct; 31(10):1334-1346. PubMed ID: 28950781
[TBL] [Abstract][Full Text] [Related]
10. The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms.
Landgraf D; Joiner WJ; McCarthy MJ; Kiessling S; Barandas R; Young JW; Cermakian N; Welsh DK
Neuropharmacology; 2016 Aug; 107():262-270. PubMed ID: 27033596
[TBL] [Abstract][Full Text] [Related]
11. Chronic antipsychotic treatment exerts limited effects on the mania-like behavior of dopamine transporter knockdown mice.
Cope ZA; Kenton JA; Minassian A; Martin MV; Perry W; Bundgaard C; Arnt J; van Enkhuizen J; Geyer MA; Young JW
Behav Brain Res; 2021 May; 405():113167. PubMed ID: 33577882
[TBL] [Abstract][Full Text] [Related]
12. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system.
Ralph-Williams RJ; Paulus MP; Zhuang X; Hen R; Geyer MA
Biol Psychiatry; 2003 Feb; 53(4):352-9. PubMed ID: 12586455
[TBL] [Abstract][Full Text] [Related]
13. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men.
Perry W; Minassian A; Paulus MP; Young JW; Kincaid MJ; Ferguson EJ; Henry BL; Zhuang X; Masten VL; Sharp RF; Geyer MA
Arch Gen Psychiatry; 2009 Oct; 66(10):1072-80. PubMed ID: 19805697
[TBL] [Abstract][Full Text] [Related]
14. Mice with reduced DAT levels recreate seasonal-induced switching between states in bipolar disorder.
Young JW; Cope ZA; Romoli B; Schrurs E; Aniek Joosen ; van Enkhuizen J; Sharp RF; Dulcis D
Neuropsychopharmacology; 2018 Jul; 43(8):1721-1731. PubMed ID: 29520059
[TBL] [Abstract][Full Text] [Related]
15. A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor.
Young JW; Minassian A; Paulus MP; Geyer MA; Perry W
Neurosci Biobehav Rev; 2007; 31(6):882-96. PubMed ID: 17706782
[TBL] [Abstract][Full Text] [Related]
16. Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features.
van Enkhuizen J; Milienne-Petiot M; Geyer MA; Young JW
Psychopharmacology (Berl); 2015 Sep; 232(18):3455-67. PubMed ID: 26141192
[TBL] [Abstract][Full Text] [Related]
17. The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania.
Milienne-Petiot M; Kesby JP; Graves M; van Enkhuizen J; Semenova S; Minassian A; Markou A; Geyer MA; Young JW
Neuropharmacology; 2017 Feb; 113(Pt A):260-270. PubMed ID: 27732870
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the dopamine transporter as an animal model of bipolar disorder mania: Locomotor response, neuroimmunological profile and pharmacological modulation.
Bastos JR; Perico KM; Marciano Vieira ÉL; Teixeira AL; Machado FS; de Miranda AS; Moreira FA
J Psychiatr Res; 2018 Jul; 102():142-149. PubMed ID: 29656188
[TBL] [Abstract][Full Text] [Related]
19. Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals.
Salahpour A; Medvedev IO; Beaulieu JM; Gainetdinov RR; Caron MG
Biol Psychiatry; 2007 Jan; 61(1):65-9. PubMed ID: 16712807
[TBL] [Abstract][Full Text] [Related]
20. Amphetamine increases activity but not exploration in humans and mice.
Minassian A; Young JW; Cope ZA; Henry BL; Geyer MA; Perry W
Psychopharmacology (Berl); 2016 Jan; 233(2):225-33. PubMed ID: 26449721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
